Singapur - Englisch - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clarithromycin - granule, for suspension - 250 mg/5 ml - clarithromycin 250 mg/5 ml

Singapur - Englisch - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clarithromycin - granule, for suspension - 125 mg/5 ml - clarithromycin 125 mg/5 ml

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

rebel distributors corp - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 10 mg in 1 ml - ciprofloxacin injection is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below when the intravenous administration offers a route of administration advantageous to the patient. please see dosage and administration for specific recommendations. urinary tract infections caused by escherichia coli (including cases with secondary bacteremia), klebsiella pneumoniae subspecies pneumoniae, enterobacter cloacae, serratia marcescens, proteus mirabilis, providencia rettgeri, morganella morganii, citrobacter diversus, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus epidermidis, staphylococcus saprophyticus, or enterococcus faecalis. lower respiratory infections caused by escherichia coli, klebsiella pneumoniae subspecies pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parainfluenzae, or penicillin-suscepti

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

sagent pharmaceuticals - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 2 mg in 1 ml - ciprofloxacin injection (in 5% dextrose injection) is indicated in adult patients for treatment of skin and skin structure infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, proteus vulgaris, providencia stuartii, morganella morganii, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus aureus, methicillin-susceptible staphylococcus epidermidis, or streptococcus pyogenes. ciprofloxacin injection is indicated in adult patients for treatment of bone and joint infections caused by enterobacter cloacae, serratia marcescens, or pseudomonas aeruginosa . ciprofloxacin injection is indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by escherichia coli, pseudomonas aeruginosa, proteus mirabilis, klebsiella pneumoniae, or bacteroides fragilis . ciprofloxacin injection is indicated in adult patients for treatment of nosocomial pneumonia caused by haemop

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - clarithromycin - oral suspension - 25mg/1ml

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - clarithromycin - oral suspension - 50mg/1ml

Malta - Englisch - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - clarithromycin - granules for oral suspension - clarithromycin 125 mg/5ml - antibacterials for systemic use

Malta - Englisch - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - clarithromycin - granules for oral suspension - clarithromycin 250 mg/5ml - antibacterials for systemic use

Südafrika - Englisch - South African Health Products Regulatory Authority (SAHPRA)

glaxosmithkline south africa (pty) limited - injection - each vial contains cefuroxime sodium equivalent to 250 mg cefuroxime

Südafrika - Englisch - South African Health Products Regulatory Authority (SAHPRA)

glaxosmithkline south africa (pty) limited - injection - each vial contains cefuroxime sodium equivalent to 750 mg cefuroxime